
The FDA has approved Bristol-Myers Squibb’s Opdivo (nivolumab) for the treatment of patients with metastatic squamous non-small cell lung cancer …

Clinical-stage biopharma firm 3-V Biosciences has taken on Dr William McCulloch as its chief medical officer. McCulloch brings nearly three …

